AG 702
Alternative Names: AG-702; AG-702/X; AG-70X; HSPPC-70-GHLatest Information Update: 07 Aug 2006
At a glance
- Originator Antigenics
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections
Most Recent Events
- 15 Mar 2006 Discontinued - Phase-I/II for Herpes simplex virus infections in USA (unspecified route)
- 31 Dec 2004 Phase-I/II clinical trials of AG 702 in Herpes simplex virus infections in USA (unspecified route)
- 25 Mar 2004 This compound is still in active development - (BioSquare-2004)